Table 3.
Relationship between histological stage and c-Kit intensity, clinicopathological and hematologic parameters
| Patch stage (n=5) | Plaque stage (n=10) | Nodular stage (n=17) | P value (¥ vs. patch group) |
|
|---|---|---|---|---|
| Age (year) | ||||
| (median [min-max]) | 67.0 (59.0-80.0) | 81.0 (51.0-98.0) | 80.0 (42.0-95.0) | 0.212*** |
| Gender (n,%) | ||||
| Male | 4 (80%) | 5 (50%) | 12 (70.59%) | 0.951** |
| Female | 1 (20%) | 5 (50%) | 5 (29.41%) | |
| Location (n,%) | ||||
| Arm | 3 (60%) | 3 (30%) | 2 (11.76%) | 0.077* |
| Leg | 1 (20%) | 7 (70%) | 12 (70.59%) | |
| Head and neck | 1 (20%) | 0 (0%) | 3 (17.65%) | |
| C-Kit intensity (n,%) | 0.364* | |||
| 0 | 2 (40%) | 3 (30%) | 5 (29.41%) | |
| + | 2 (40%) | 3 (30%) | 3 (17.65%) | |
| ++ | 0 (0%) | 2 (20%) | 4 (23.53%) | |
| +++ | 1 (20%) | 2 (20%) | 5 (29.41%) | |
| Ki-67 (%) | 3.0 (1.0-5.0) | 10.0 (1.0-20.0)¥ | 5.0 (2.0-20.0) | ¥0.042*** |
| (median [min-max]) | ||||
| Mean platelet volume (fL) | 7.1 (6.8-9.8) | 8.0 (6.0-10.4) | 8.3 (6.3-11.2) | 0.371*** |
| (median [min-max]) | ||||
| Platelets (×109/L) | 268.0 (146.0-322.0) | 199.0 (171.0-251.0) | 254.0 (132.0-420.0) | 0.130*** |
| (median [min-max]) | ||||
| White blood cell (×109/L) | 7.4 (6.5-10.6) | 6.3 (4.2-9.4)¥ | 6.4 (3.5-11.3) | ¥0.037*** |
| (median [min-max]) | ||||
| Hemoglobin (g/dL) | 13.6 (11.5-16.8) | 13.2 (9.8-16.1) | 13.8 (12.0-16.2) | 0.634*** |
*
p value was calculated by Chi square test;
**
p value was calculated by Fisher’s exact test;
***
p value was calculated by Kruskal-Wallis test